Wikidata

(Q33383835)

English

Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors.

scientific article

In more languages

Statements

title
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19308410
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308410%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33383835&oldid=2195307438"